US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated

Archived

Centers for Disease Control and Prevention - ERA

View on Grants.gov 📝 Build a proposal template ★ Save

Description

The goal of this funding announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza vaccine effectiveness (VE) to preventinfluenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with acute respiratory illness (ARI), confirm influenza infection using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design.

Who can apply

  • Others

Contact

Centers for Disease Control and Prevention (CDC) <br/>Procurement and Grants Office (PGO) <br/>Phone: 770-488-2700 <br/>
pgotim@cdc.gov

Key dates & funding
  • PostedJan 13, 2015
  • ClosesMar 3, 2015
  • Award floor$275,000
  • Award ceiling$300,000
  • Program funding$11,600,000
  • Expected awards4
  • CFDA93.185
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro